Citations to this article

Gerald W. Dorn II, Thomas Force
Published in Volume 115, Issue 3
J Clin Invest. 2005; 115(3):527–537 doi:10.1172/JCI24178

Total citations by year in Crossref

Year: 2013 2012 2011 2009 2008 2007 2006 2005 Total
Citations: 1 1 3 3 7 13 11 5 44
Citation information

Citations to this article in Crossref (44)

Title and authors Publication Year
Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
F Billia, L Hauck, D Grothe, F Konecny, V Rao, RH Kim, TW Mak
Proceedings of the National Academy of Sciences 2013
Redox regulation of sodium and calcium handling
S Wagner, A Rokita, ME Anderson, LS Maier
Antioxidants & Redox Signaling 2012
Selective deletion of long but not short Cypher isoforms leads to late-onset dilated cardiomyopathy
H Cheng, M Zheng, AK Peter, K Kimura, X Li, K Ouyang, T Shen, L Cui, D Frank, ND Dalton, Y Gu, N Frey, KL Peterson, SM Evans, KU Knowlton, F Sheikh, J Chen
Human Molecular Genetics 2011
Scaffold-Based Transplantation of Akt1 -Overexpressing Skeletal Myoblasts: Functional Regeneration Is Associated with Angiogenesis and Reduced Infarction Size
M Siepe, P Golsong, A Poppe, B Blumenthal, R Wattenwyl, C Heilmann, K Förster, C Schlensak, F Beyersdorf
Tissue Engineering Part A 2011
Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size
M Xin, Y Kim, LB Sutherland, X Qi, J McAnally, RJ Schwartz, JA Richardson, R Bassel-Duby, EN Olson
Science signaling 2011
CHF1/Hey2 Promotes Physiological Hypertrophy in Response to Pressure Overload through Selective Repression and Activation of Specific Transcriptional Pathways
M Yu, Y Liu, F Xiang, Y Li, D Cullen, R Liao, RP Beyer, TK Bammler, MT Chin
OMICS: A Journal of Integrative Biology 2009
Selective activation of PI3K /Akt/GSK-3  signalling and cardiac compensatory hypertrophy during recovery from heart failure
JC Braz, RM Gill, AK Corbly, BD Jones, N Jin, CJ Vlahos, Q Wu, W Shen
European Journal of Heart Failure 2009
Regulation of phospholipase C in cardiac hypertrophy
PS Tappia, T Singal
Clinical Lipidology 2009
Effects of Hawthorn on Cardiac Remodeling and Left Ventricular Dysfunction after 1 Month of Pressure Overload-induced Cardiac Hypertrophy in Rats
HS Hwang, BE Bleske, MM Ghannam, K Converso, MW Russell, JC Hunter, MO Boluyt
Cardiovascular Drugs and Therapy 2008
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
GW 2nd
Cardiovascular Research 2008
Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes
JS Martini, P Raake, LE Vinge, BR DeGeorge, B DeGeorge, JK Chuprun, DM Harris, E Gao, AD Eckhart, JA Pitcher, WJ Koch
Proceedings of the National Academy of Sciences 2008
Genomics in cardiac metabolism
JL Samuel, MC Schaub, M Zaugg, M Mamas, WB Dunn, B Swynghedauw
Cardiovascular Research 2008
Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of  1-adrenoceptors
M Endoh
Cardiovascular Research 2008
Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1  and CREB
J Feng, E Lucchinetti, G Fischer, M Zhu, K Zaugg, MC Schaub, M Zaugg
Cardiovascular Research 2008
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
K Lorenz, JP Schmitt, EM Schmitteckert, MJ Lohse
Nature Medicine 2008
Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine
AS Araujo, AT Enzveiler, P Schenkel, TR Fernandes, MF Ribeiro, WA Partata, S Llesuy, A Belló-Klein
Molecular and Cellular Biochemistry 2007
Phospholipid-mediated signaling systems as novel targets for treatment of heart diseaseThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigators' Forum
PS Tappia
Canadian Journal of Physiology and Pharmacology 2007
Adenoviral Expression of Calmodulin Antisense Reduces Hypertrophy in Cultured Cardiomyocytes
LH Arruda, IA Cestari, AA Leirner, IN Cestari
Artificial Organs 2007
The upper limit of physiological cardiac hypertrophy in elite male and female athletes in China
B SUN, JZ MA, YH YONG, YY LV
European Journal of Applied Physiology 2007
Glycogen Synthase Kinase-3β—Actively Inhibiting Hypertrophy
R Kerkelä, K Woulfe, T Force
Trends in Cardiovascular Medicine 2007
Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy
G Simonis, SK Briem, SP Schoen, M Bock, R Marquetant, RH Strasser
Molecular and Cellular Biochemistry 2007
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
TA McKinsey, DA Kass
Nature Reviews Drug Discovery 2007
Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice
A Diwan, M Krenz, FM Syed, J Wansapura, X Ren, AG Koesters, H Li, LA Kirshenbaum, HS Hahn, J Robbins, WK Jones, GW Dorn
Journal of Clinical Investigation 2007
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
CM Trivedi, Y Luo, Z Yin, M Zhang, W Zhu, T Wang, T Floss, M Goettlicher, PR Noppinger, W Wurst, VA Ferrari, CS Abrams, PJ Gruber, JA Epstein
Nature Medicine 2007
Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy
HL Li, R Yin, D Chen, D Liu, D Wang, Q Yang, YG Dong
Journal of Cellular Biochemistry 2007

Advertisement